Goldman Sachs reports a passive stake above 5% in Pacific Biosciences (PACB).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, have reported a beneficial ownership of 23,515,936 shares, or 7.6%, in Pacific Biosciences of California, Inc. (PACB). This passive investment disclosure was made via a SCHEDULE 13G SEC filing, indicating shared voting and disposition power over the reported shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.